Brain scans reveal hidden damage in glaucoma patients

NCT ID NCT01621841

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study used high-powered 3-Tesla MRI to compare the visual pathways in the brains of 114 people with glaucoma and healthy volunteers. Researchers looked at the structure and volume of brain areas involved in vision to see if glaucoma causes damage beyond the eye. The goal was to better understand how glaucoma progresses and its possible links to other brain diseases like Alzheimer's.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better understand how glaucoma affects the brain's visual pathways, potentially leading to earlier detection or new treatment targets.
What could go wrong: This is an observational imaging study, not a treatment trial. It cannot directly improve patient outcomes, and its findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRACTIONAL ANISOTROPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRACTIONAL ANISOTROPY GLAUCOMA

Contacts and locations

Locations

Service d'ophtalmologie Hôpital Pellegrin

CHU de Bordeaux, Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.